Fiche publication


Date publication

septembre 2024

Journal

European heart journal

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves


Tous les auteurs :
Wang Y, Zeller M, Auffret V, Georgiopoulos G, Räber L, Roffi M, Templin C, Muller O, Liberale L, Ministrini S, Stamatelopoulos K, Stellos K, Camici GG, Montecucco F, Rickli H, Maza M, Radovanovic D, Cottin Y, Chague F, Niederseer D, Lüscher TF, Kraler S

Résumé

and aims: Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. To test novel interventions, personalized risk prediction is essential. The ORBI (Observatoire Régional Breton sur l'Infarctus) score represents the first-of-its-kind risk score to predict in-hospital CS in ACS patients undergoing percutaneous coronary intervention (PCI). However, its sex-specific performance remains unknown, and refined risk prediction strategies are warranted.

Mots clés

C-reactive protein, LVEF, acute coronary syndromes, atherosclerosis, cardiogenic shock, gender medicine, inflammation, machine learning, multilayer perceptron, percutaneous coronary intervention, personalized risk prediction, precision medicine, random forest

Référence

Eur Heart J. 2024 09 1;: